StonvexLoading…
StonvexStonvexStonvexCore line items from PTHS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 |
|---|---|---|
Revenue | $16.80M | $0.00 |
Operating Income | $-32.43M | $-7.57M |
Net Income | $-43.32M | $-7.96M |
EPS (Diluted) | $-23.04 | $-14.27 |
Total Assets | $130.40M | $1.37M |
Total Liabilities | $91.52M | $4.08M |
Cash & Equivalents | $17.97M | $513.00K |
Free Cash Flow OCF − CapEx | $-22.69M | $-5.79M |
Shares Outstanding | 3.23M | 610.39K |